Observational study on adjuvant trastuzumab in HER2-positive early breast cancer patients

Future Oncology ◽

10.2217/fon.15.34 ◽

2015 ◽

Vol 11 (10) ◽

pp. 1493-1500 ◽

Author(s):

G Mustacchi ◽

F Puglisi ◽

AM Molino ◽

D Crivellari ◽

C Ghiotto ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Early Breast Cancer ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Adjuvant Trastuzumab

Download Full-text

226P Impact of BMI on outcome and cardiac safety in HER2-positive breast cancer patients treated with adjuvant trastuzumab: Results of a monocentric observational study

Annals of Oncology ◽

10.1016/j.annonc.2020.08.347 ◽

2020 ◽

Vol 31 ◽

pp. S331

Author(s):

C. Molinelli ◽

L. Del Mastro ◽

S. Giraudi ◽

A. Ballestrero ◽

F. Carli ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Cardiac Safety ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Her2 Positive Breast Cancer ◽

Positive Breast Cancer

Download Full-text

T-DM1 EFFICACY AND ACTIVITY IN HER2-POSITIVE METASTATIC BREAST CANCER PATIENTS PROGRESSING AFTER FRONTLINE TAXANE PLUS PERTUZUMAB AND TRASTUZUMAB: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY OF THE GRUPPO ITALIANO MAMMELLA (GIM) STUDY GROUP

10.1016/s0960-9776(19)30674-5 ◽

2019 ◽

Vol 48 ◽

pp. S45

Author(s):

Benedetta Conte ◽

Alessandra Fabi ◽

Francesca Poggio ◽

Eva Blondeaux ◽

Chiara Dellepiane ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Observational Study ◽

Cancer Patients ◽

Metastatic Breast ◽

Study Group ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Multicenter Observational Study

Download Full-text

Additional Safety Results of Hannah: A Phase III Randomised, Open-Label, International Study of the Subcutaneous Formulation of Trastuzumab (H) in HER2-Positive Early Breast Cancer Patients

Annals of Oncology ◽

10.1016/s0923-7534(20)32833-7 ◽

2012 ◽

Vol 23 ◽

pp. ix102-ix103

Author(s):

C. Jackisch ◽

M. Dank ◽

G. Frasci ◽

K.H. Park ◽

R.I. Lopez ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

International Study ◽

Phase Iii ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Additional Safety

Download Full-text

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients

International Journal of Clinical Oncology ◽

10.1007/s10147-015-0785-8 ◽

2015 ◽

Vol 20 (4) ◽

pp. 709-722 ◽

Author(s):

Hiroyasu Yamshiro ◽

Hiroji Iwata ◽

Norikazu Masuda ◽

Naohito Yamamoto ◽

Reiki Nishimura ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Trastuzumab Therapy

Download Full-text

Abstract P5-10-18: The chromosomal genomic landscape and targetable co-amplified genes in HER2 positive breast cancer patients who relapsed on an adjuvant trastuzumab chemotherapy trial

10.1158/1538-7445.sabcs14-p5-10-18 ◽

2015 ◽

Author(s):

Shelly Gunn ◽

Chris McCaskill ◽

Linda Daley ◽

Agnes Puskas ◽

Lina Asmar ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Her2 Positive Breast Cancer ◽

Genomic Landscape ◽

Positive Breast Cancer

Download Full-text

Long-term Outcome of HER2-positive Early Breast Cancer Patients in the Trastuzumab Era: a Single Centre Experience

Clinical Oncology ◽

10.1016/j.clon.2017.01.012 ◽

2017 ◽

Vol 29 (6) ◽

pp. e97

Author(s):

P. Aravind ◽

C. Jingree ◽

F. Castell ◽

A. Rigg

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

Breast Cancer Patients ◽

Single Centre ◽

Her2 Positive ◽

Term Outcome ◽

Long Term Outcome ◽

Single Centre Experience

Download Full-text

Real-life effectiveness of T-DM1 in heavily pretreated HER2-positive advanced breast cancer patients: An Italian observational study.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e12019 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e12019-e12019 ◽

Author(s):

Alessandra Fabi ◽

Katia Cannita ◽

Gianluigi Ferretti ◽

Mariangela Ciccarese ◽

Grazia Arpino ◽

...

Keyword(s):

Breast Cancer ◽

Observational Study ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Real Life ◽

Advanced Breast ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Life Effectiveness ◽

Heavily Pretreated

Download Full-text

Adjuvant chemotherapy for HER2-positive early breast cancer patients without perioperative radiotherapy in trastuzumab era.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e12573 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e12573-e12573

Author(s):

Kazuki Nozawa ◽

Keiji Sugiyama ◽

Kazuhiro Shiraishi ◽

Yoriko Funahashi ◽

Yoshihito Kogure ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Early Breast Cancer ◽

Breast Cancer Patients ◽

Download Full-text

Clinical Outcome of HER2-positive Breast Cancer Patients after Failure on Adjuvant Trastuzumab: The Potential of the Time to Relapse

Clinical Oncology ◽

10.1016/j.clon.2013.11.028 ◽

2014 ◽

Vol 26 (3) ◽

pp. 174

Author(s):

S. Di Cosimo ◽

D. Serpico ◽

L. Porcu ◽

L. Molino ◽

G. Fanetti ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Outcome ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Adjuvant Trastuzumab ◽

Her2 Positive Breast Cancer ◽

Time To Relapse ◽

Positive Breast Cancer

Download Full-text

Erratum to: Outcomes of trastuzumab therapy in HER2‑positive early breast cancer patients

International Journal of Clinical Oncology ◽

10.1007/s10147-015-0814-7 ◽

2015 ◽

Vol 20 (4) ◽

pp. 723-724

Author(s):

Hiroyasu Yamshiro ◽

Hiroji Iwata ◽

Norikazu Masuda ◽

Naohito Yamamoto ◽

Reiki Nishimura ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Early Breast Cancer ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Trastuzumab Therapy

Download Full-text